A 54-year-old man began to feel numbness in his hands at the age of 42 (1975). His condition became progressively worse accompanied by muscle weakness of the lower limbs and glove and stocking paresthesia of the extremities. The patient was admitted to our hospital on March 23, 1987. Neurological examination revealed distal dominant muscle weakness, sensory disturbance and areflexia. Electrocardiogram and ultrasoundcardiogram strongly suggested cardiomyopathy. A biopsy of the rectal wall and the cardiac muscle revealed amyloid deposits. The patient, his elder brother and one of his daughters had abnormal serum transthyretin (TTR, a protein referred as prealbumin). Therefore, the diagnosis of familial amyloidotic polyneuropathy (FAP) was confirmed. The patient's brother and daughter mentioned above, however, had no abnormal findings on physical examination and they were thus considered to be asymptomatic carriers. There maybe more cases of asymptomatic carriers, if examination of abnormal TTRis more frequently analyzed.
Neurological examination revealed nothing abnormal in the mental status and cranial nerves, but he showed muscle weakness and atrophy in distal muscles. The grasping power was 7 kg. There was severe symmetrical disturbance of touch and pain sensation in the distal parts of all extremities. In addition, vibratory sensation was remarkably lost. The Achilles reflex was absent and other deep tendon reflexes were decreased. The Babinski reflex was absent. He showed a slight gate disturbance.
Laboratory data
In the laboratory data, there were no abnormalities with the exception of triglyceride, GPT, LAP and r-GTP levels. M-component was not detected on an electrophoresis. The results of the bone marrowstudy were unremarkable.
The posterolateral chest X-ray film showed slight cardiomegaly, and the cardio-thoracic ratio was 48 %. An electrocardiogram showed frequent atrial premature beats. The QRSaxis was -80°and there was QS deflection in leads Yl through V4 (Fig. 1 ).
An ultrasound-cardiogram revealed a thickening of the interventricular septum (IVS) and posterior wall, and also a granular sparkling appearance was seen in the IVS (Fig. 2) . The planar image of the thallium-201 myocardial scintigram was normal (Fig. 3a) . The planar image of the technetium-99m-pyrophosphate myocardial scintigram showed diffuse and intense biventricular uptake of radionuclide (Fig. 3b) . Cerebro-spinal fluid by lumbar puncture revealed 150 mmH2Oinitial pressure and the fluid was clear, with a cell count of 3/mm3 (lymphocyte), protein 83 mg/ml, and sugar 64 mg/dl. Motor nerve conduction velocity measured in the median nerve was 35 m/sec. Sensory conduction velocity was not measurable due to the lack of a response. A nerve biopsy was performed at the sural nerve; Kluever-Barrera stained tissue showed nerve loss, but no abnormal deposits. The biopsy of cardiac muscle and rectal wall showed amyloid deposits. Microscopic examination of the cardiac muscle tissue showed amyloid deposits surrounding the myocardial fiber (Fig. 4a) . Also microscopic examination of the rectal wall revealed amyloid deposits in the lamina muscularis mucosae (Fig. 4b) . The amyloid fibril was determined to be non-AA protein as it was stained with Congored even after exposure to potassium permanganate and dilute The serum level of the abnormal TTRby RIA (3) was determined to be 1 1.29 mg/dl. In the familial study to which we referred, the patient's elder brother and one of his daughters had a high level of serum abnormal TTR (Fig. 5) (4) . Amyloid was confirmed by biopsy of the cardiac muscle and rectal wall, and was stained by antitransthyretin antiserum. These clinical manifestations and electrocardiogram and neuropathologic findings were consistent with those of classical FAP. Wediagnosed this case as FAP. Although the patient had no family history of FAP, two in his family had abnormal TTR, especially his elder brother, who at the age of 62, was asymptomatic far beyond the usual age of onset of FAP. Since FAPis inherited as an autosomal dominant trait, and definite family history is usually present, we concluded that he was an aged asymptomaticcarrier of FAP. This FAPcase is noteworthy because his elder brother and daughter had no symptomsof FAP, although they showed a higher abnormal TTRlevel than the patient. Until recently, it was thought that FAP did not skip generations and did not have asymptomatic carriers (5) . However, there are some reports of spontaneous cases (6-8) and asymptomatic carriers (9). From these findings it can be concluded that the patients who have abnormal serum TTR do not always have FAP. And there may be families with FAPwhich have not been discovered as there is no one with the symptoms.Thepatient's father lived to be 81 and his mother, 68, but they had no symptoms of FAP. As also his elder brother has no symptoms,wesuspect that the carrier in this family is probably asymptomatic. In the reports on asymptomatic carriers to the present, only females have been considered to be asymptomatic carriers (9), but we believe that there is a male asymptomatic carrier in this family. Recently, abnormal serum TTRlevel has been said not to be consistently related to the period of onset, duration of illness or the condition (9-ll). In FAP, there may be unknown genetic factors in addition to gender. The onset of FAP is usually in the second or third decade, but in patients with FAPin Japan and Portugal, the onset has been as late as the fifth or sixth decade (12), and the progression after onset has been rapid. The course of the illness is progressive and invariably leads to death. The late onset type of FAP usually begins after the fourth decade (13). The initial symptoms in this case appeared at 42 years of age, and gate disturbance appeared ten years later. So this seems to suggest that this case is the late onset type. It cannot be determined whether the asymptomatic carriers are independent of the late onset type or whether they die before the onset. The patient's elder brother, an asymptomatic carrier, must be followed carefully to determine whether he shows any clinical signs of the disease or not, and his daughter in the period of onset will also have to be followed carefully. Although this family has abnormal serum TTR Japan, the proposita progressed very slowly and two carriers in this family are still asymptomatic. These phenomenaare very important in the understanding of the mechanismof onset and the treatment of FAP. If FAP was classified into benign FAP (late onset type or asymptomaticcarrier with slow progression after onset) and malignant FAP (typical onset type, complete penetrance and early progression after onset), the benign FAP, in a family such as this one, could be discovered muchmore readily by using biochemical studies to determine the abnormal TTR.
